Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Schorno Dean L
EVP & Chief Financial Officer at RIGEL PHARMACEUTICALS. Filing since 22 May 2019.
CIK 0001509688
Company
Date
Role
Action
Shares
Amount
Of holding
RIGL
RIGEL PHARMACEUTICALS INC
5 Feb 2025
EVP & Chief Financial Officer
Sold at will
1,734
$38.02K
2.9%
RIGL
RIGEL PHARMACEUTICALS INC
4 Feb 2025
EVP & Chief Financial Officer
Sold at will
2,036
$42.60K
3.3%
RIGL
RIGEL PHARMACEUTICALS INC
5 Feb 2024
EVP & Chief Financial Officer
Sold at will
7,027
$8.01K
1.7%
RIGL
RIGEL PHARMACEUTICALS INC
2 Feb 2024
EVP & Chief Financial Officer
Sold at will
5,601
$6.33K
1.3%
RIGL
RIGEL PHARMACEUTICALS INC
2 Feb 2023
EVP & Chief Financial Officer
Sold, plan not stated
5,389
$8.95K
2.7%
RIGL
RIGEL PHARMACEUTICALS INC
22 May 2019
EVP &Chief Financial Officer
Bought
50,000
$106.54K
opened
6 decisions on file.
